2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Tuesday, September 24, 2019

1:45pm-3:15pm: The effect of baseline cognitive status of Parkinson’s disease on the outcome after deep brain stimulation surgery

KW. Park, NR. Choi, SY. Jo, MS. Kim, NE. Han, SR. Jeon, SJ. Chung (Seoul, Republic of Korea)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: The effect of coexistent neurodegenerative disorders on the clinical features of idiopathic normal pressure hydrocephalus

A. Hattori, T. Tsunemi, N. Hattori (Bunkyo-Ku, Japan)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: The effect of Guided Self-rehabilitation Contracts combined with simultaneous injections of abobotulinumtoxinA into upper and lower limbs on voluntary movements in adults with spastic hemiparesis

J-M. Gracies, G. Francisco, R. Jech, S. Khatkova, C. Rios, P. Maisonobe (Créteil, France)

Spasticity · Les Muses Terrace, Level 3

1:45pm-3:15pm: The effect of Kinesio Taping therapy on Cervical Dystonia

J. Magalhães, A. Rosso, F. Rezende (Rio de Janeiro, Brazil)

Dystonia · Les Muses Terrace, Level 3

1:45pm-3:15pm: The Effects of Computer Based Cognitive Rehabilitation on working memory in patients with Parkinson’s disease: A Systematic Review

A. Loekkegaard, M. Niemeijer, K. Svaerke (Copenhagen, Denmark)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: The effects of obstacle size and timing on prefrontal cortex activation in patients with Parkinson’s disease

I. Maidan, T. Sharon, I. Kurz, H. Bernad-Elazari, S. Shustak, I. Galperin, N. Giladi, A. Mirelman, J. Hausdorff (Tel Aviv, Israel)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: The effects of onabotulinum toxin on neurophysiological tests in patients with hemifacial spasm

O. Kocak, A. Tokcaer (Ankara, Turkey)

Neurophysiology · Les Muses Terrace, Level 3

1:45pm-3:15pm: The effects of timed exposure to bright light in improving the gait patterns of patients with Parkinson’s disease – A pilot study

L. Alibiglou, T. Ruopp (Tehran, Islamic Republic of Iran)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: The effects of zonisamide on motor and non-motor symptoms in patients with Parkinson’s disease: a 3-month open-label study

K. Suzuki, H. Fujita, T. Matsubara, T. Kadowaki, K. Funakoshi, Y. Watanabe, T. Shiina, H. Sakuramoto, M. Hamaguchi, K. Hirata (Tochigi, Japan)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: The Efficacy and Safety of Subcutaneous Apomorphine in Patients with Parkinson’s Disease: A Meta-Analysis Randomized Controlled Trials

M. Azharuddin, M. Adil, P. Ghosh, M. Sharma (New Delhi, India)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3